Role of GLCCI1 in inhibiting PI3K-induced NLRP3 inflammasome activation in asthma
Yingyu Zhang, Yuanyuan Jiang, Daimo Zhang, Xinyue Hu, Shuanglinzi Deng, Xiaozhao Li, Juntao Feng · 2024
Read Role of GLCCI1 in inhibiting PI3K-induced NLRP3 inflammasome activation in asthma by Yingyu Zhang, Yuanyuan Jiang, Daimo Zhang, Xinyue Hu, Shuanglinzi Deng, Xiaozhao Li, Juntao Feng (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11742361.txt.
Description
Yingyu Zhang and co-authors show that a steroid-linked gene acts as a brake on a fiery inflammation pathway in asthma, in this 2024 paper. The gene, GLCCI1, was already tied to how well inhaled steroids work. In sputum cells from asthma patients, its levels ran low, and lower levels tracked higher activity of the NLRP3 inflammasome and its PI3K driver.
Mice lacking the gene developed worse airway inflammation and stronger inflammasome firing. A drug blocking the PI3K pathway calmed normal asthmatic mice partly by raising the gene's levels in lung macrophages. Without the gene, that drug lost much of its power. Dish experiments pinned the order of events. The authors cast GLCCI1 as a needed middleman in steroid-linked asthma control.
Catalog record
| CREATOR | Yingyu Zhang, Yuanyuan Jiang, Daimo Zhang, Xinyue Hu, Shuanglinzi Deng, Xiaozhao Li, Juntao Feng |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |